Two additional TaqI RFLPs in von Willebrand factor gene (VWF) and pseudogene.

Por Marchetti, G, Sacchi, E, Patracchini, P, Randi, A M, Sampietro, M, Bernardi, F
Publicado em 1989

Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.

Por Randi, A M, Rabinowitz, I, Mancuso, D J, Mannucci, P M, Sadler, J E
Publicado em 1991

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.

Por Rabinowitz, I, Tuley, E A, Mancuso, D J, Randi, A M, Firkin, B G, Howard, M A, Sadler, J E
Publicado em 1992

Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation

Por Thornton, C C, Al-Rashed, F, Calay, D, Birdsey, G M, Bauer, A, Mylroie, H, Morley, B J, Randi, A M, Haskard, D O, Boyle, J J, Mason, J C
Publicado no Ann Rheum Dis (2016)

The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability

Por Shah, A. V., Birdsey, G. M., Peghaire, C., Pitulescu, M. E., Dufton, N. P., Yang, Y., Weinberg, I., Osuna Almagro, L., Payne, L., Mason, J. C., Gerhardt, H., Adams, R. H., Randi, A. M.
Publicado no Nat Commun (2017)